We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Agilent Q1 Earnings Miss Estimates, Revenues Up Y/Y, Shares Fall
Read MoreHide Full Article
Key Takeaways
Agilent reported Q1 EPS of $1.36, up Y/Y, while revenues rose 7% to $1.8 billion.
Agilent saw revenue growth across LDG, ACG, and AMG, but segment margins declined Y/Y.
Agilent guided Q2 revenues of $1.79-$1.82B and FY26 sales of $7.3-$7.5B.
Agilent Technologies (A - Free Report) reported first-quarter fiscal 2025 earnings of $1.36 per share, which missed the Zacks Consensus Estimate by 0.52%. The figure increased 3.8% year over year.
Revenues of $1.8 billion surpassed the Zacks Consensus Estimate by 0.27%. The top line increased 7% on a reported basis and 4.4% on a core basis (excluding acquisitions and divestitures) year over year.
Agilent shares are down 0.06% in the pre-market trading.
Agilent’s Q1 Top-Line Details
The company operates through three reporting segments—Life Sciences and Diagnostics Markets Group (“LDG”), Agilent CrossLab Group (“ACG”) and Applied Markets Group (“AMG”).
Agilent Technologies, Inc. Price, Consensus and EPS Surprise
LDG: The segment generated $679 million and accounted for 37.8% of the company’s total revenues. This represented a 5% increase on a reported basis and a 3% rise on a core basis year over year.
ACG: Revenues from the segment were $758 million, accounting for 42.2% of the total revenues. The top line grew 9% on a reported basis and 6% on a core basis year over year.
AMG: Revenues increased 7% year over year to $361 million on a reported and 4% on a core basis, accounting for the remaining 20.1% of the total revenues.
Agilent’s Q1 Operating Results
For the first quarter of fiscal 2026, the LDG segment’s gross margin contracted 230 basis points (bps) year over year to 50.5%. ACG’s gross margin decreased 90 bps year over year to 55.2%, while AMG’s gross margin declined 70 bps year over year to 56.5%.
Research and development (R&D) expenses on a non-GAAP basis were $117 million, up 4.5% from the prior-year quarter. Selling, general and administrative (SG&A) expenses on a non-GAAP basis rose to $406 million, marking a 5.2% increase from the prior-year quarter.
As a percentage of revenues, R&D expenses fell 20 bps year over year to 6.5%, while SG&A expenses fell 40 bps year over year to 22.6%.
The non-GAAP operating margin of 24.6% for the fiscal first quarter contracted 50 bps on a year-over-year basis.
Segment-wise, LDG operating margin decreased 200 bps year over year to 16.1%. ACG’s operating margin fell 10 bps year over year to 31.7%. Meanwhile, AMG’s operating margin contracted 90 bps year over year to 25.8%.
A’s Balance Sheet Details
As of Jan. 31, 2026, Agilent’s cash and cash equivalents were $1.75 billion, up from $1.78 billion as of Oct. 31, 2025.
The long-term debt was $3.05 billion as of Jan. 31, 2026, unchanged from the previous quarter.
Agilent’s Q2 & FY26 Guidance
For the second quarter of fiscal 2026, Agilent expects revenues in the range of $1.79-$1.82 billion, indicating a rise of 7% to 9% on a reported basis and 4% to 5.5% on a core basis. Non-GAAP earnings are expected to be between $1.39 per share and $1.42 per share.
For fiscal 2026, Agilent expects revenues between $7.3 billion and $7.5 billion, implying an increase of 5.5-7.5% on a reported basis and 4-6% on a core basis. The company expects non-GAAP earnings between $5.90 per share and $6.04 per share.
A’s Zacks Rank & Stocks to Consider
Currently, Agilent carries a Zacks Rank #3 (Hold).
ATN International is set to report fourth-quarter 2025 results on March 5. ATN International shares have surged 76.4% in the trailing six-month period.
Broadcom is slated to report first-quarter fiscal 2026 results on March 4. Broadcom shares have gained 11.5% in the trailing six-month period.
Credo Technology is set to report third-quarter fiscal 2026 results on March 2. Credo Technology shares have gained 2.8% in the trailing six-month period.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Agilent Q1 Earnings Miss Estimates, Revenues Up Y/Y, Shares Fall
Key Takeaways
Agilent Technologies (A - Free Report) reported first-quarter fiscal 2025 earnings of $1.36 per share, which missed the Zacks Consensus Estimate by 0.52%. The figure increased 3.8% year over year.
Revenues of $1.8 billion surpassed the Zacks Consensus Estimate by 0.27%. The top line increased 7% on a reported basis and 4.4% on a core basis (excluding acquisitions and divestitures) year over year.
Agilent shares are down 0.06% in the pre-market trading.
Agilent’s Q1 Top-Line Details
The company operates through three reporting segments—Life Sciences and Diagnostics Markets Group (“LDG”), Agilent CrossLab Group (“ACG”) and Applied Markets Group (“AMG”).
Agilent Technologies, Inc. Price, Consensus and EPS Surprise
Agilent Technologies, Inc. price-consensus-eps-surprise-chart | Agilent Technologies, Inc. Quote
LDG: The segment generated $679 million and accounted for 37.8% of the company’s total revenues. This represented a 5% increase on a reported basis and a 3% rise on a core basis year over year.
ACG: Revenues from the segment were $758 million, accounting for 42.2% of the total revenues. The top line grew 9% on a reported basis and 6% on a core basis year over year.
AMG: Revenues increased 7% year over year to $361 million on a reported and 4% on a core basis, accounting for the remaining 20.1% of the total revenues.
Agilent’s Q1 Operating Results
For the first quarter of fiscal 2026, the LDG segment’s gross margin contracted 230 basis points (bps) year over year to 50.5%. ACG’s gross margin decreased 90 bps year over year to 55.2%, while AMG’s gross margin declined 70 bps year over year to 56.5%.
Research and development (R&D) expenses on a non-GAAP basis were $117 million, up 4.5% from the prior-year quarter. Selling, general and administrative (SG&A) expenses on a non-GAAP basis rose to $406 million, marking a 5.2% increase from the prior-year quarter.
As a percentage of revenues, R&D expenses fell 20 bps year over year to 6.5%, while SG&A expenses fell 40 bps year over year to 22.6%.
The non-GAAP operating margin of 24.6% for the fiscal first quarter contracted 50 bps on a year-over-year basis.
Segment-wise, LDG operating margin decreased 200 bps year over year to 16.1%. ACG’s operating margin fell 10 bps year over year to 31.7%. Meanwhile, AMG’s operating margin contracted 90 bps year over year to 25.8%.
A’s Balance Sheet Details
As of Jan. 31, 2026, Agilent’s cash and cash equivalents were $1.75 billion, up from $1.78 billion as of Oct. 31, 2025.
The long-term debt was $3.05 billion as of Jan. 31, 2026, unchanged from the previous quarter.
Agilent’s Q2 & FY26 Guidance
For the second quarter of fiscal 2026, Agilent expects revenues in the range of $1.79-$1.82 billion, indicating a rise of 7% to 9% on a reported basis and 4% to 5.5% on a core basis. Non-GAAP earnings are expected to be between $1.39 per share and $1.42 per share.
For fiscal 2026, Agilent expects revenues between $7.3 billion and $7.5 billion, implying an increase of 5.5-7.5% on a reported basis and 4-6% on a core basis. The company expects non-GAAP earnings between $5.90 per share and $6.04 per share.
A’s Zacks Rank & Stocks to Consider
Currently, Agilent carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader Zacks Computer and Technology sector are ATN International (ATNI - Free Report) , Broadcom (AVGO - Free Report) , and Credo Technology (CRDO - Free Report) . While Credo Technology sports a Zacks Rank #1 (Strong Buy), ATN International and Broadcom carry a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
ATN International is set to report fourth-quarter 2025 results on March 5. ATN International shares have surged 76.4% in the trailing six-month period.
Broadcom is slated to report first-quarter fiscal 2026 results on March 4. Broadcom shares have gained 11.5% in the trailing six-month period.
Credo Technology is set to report third-quarter fiscal 2026 results on March 2. Credo Technology shares have gained 2.8% in the trailing six-month period.